Wednesday, May 28, 2025 6:30:34 PM
I'm not sure if both of you aren't right. In October I have a feeling the company did say something like the document was ready for review, both in house and by contractors, but it wasn't a submission to the regulator.
It was submitted late in December, preliminary validated in late January, and not finally validated for a couple more months. What difference does it make as to what we believe the start date was.
If the regulator is saying they're still on time, I guess that's saying they've not yet spent 150 days that were considered to be on the clock. I guess it's up to them to say, this day is on the clock, this one isn't, it's their clock, so they're in control of it.
The company had said that they'd yet to receive a RFI well after the time the guidance said they should, regardless of which start date is chosen, so apparently they could have some off the clock dates even while they're the only ones dealing with the filing.
For all we know they could make a decision tomorrow, or it could be six more months, and they would still say they're on schedule. Apparently, whether it's a member of Parliament, or some other official that asks, saying we're on schedule get the job done, regardless of how long it's been since they started.
Our FDA doesn't always meet their PDUFA dates, but they do officially reschedule them so a new target is established. Other regulators seem to all push for 150 days on the clock with time off for RFI's, but don't seem to care if it takes years to finish the process, they just say they're on time.
I don't care if it's the FDA or other regulators, they're the judge and only a fool criticizes or questions the judge, even after a trial, if it's believed that some day they may be judged again.
Gary
It was submitted late in December, preliminary validated in late January, and not finally validated for a couple more months. What difference does it make as to what we believe the start date was.
If the regulator is saying they're still on time, I guess that's saying they've not yet spent 150 days that were considered to be on the clock. I guess it's up to them to say, this day is on the clock, this one isn't, it's their clock, so they're in control of it.
The company had said that they'd yet to receive a RFI well after the time the guidance said they should, regardless of which start date is chosen, so apparently they could have some off the clock dates even while they're the only ones dealing with the filing.
For all we know they could make a decision tomorrow, or it could be six more months, and they would still say they're on schedule. Apparently, whether it's a member of Parliament, or some other official that asks, saying we're on schedule get the job done, regardless of how long it's been since they started.
Our FDA doesn't always meet their PDUFA dates, but they do officially reschedule them so a new target is established. Other regulators seem to all push for 150 days on the clock with time off for RFI's, but don't seem to care if it takes years to finish the process, they just say they're on time.
I don't care if it's the FDA or other regulators, they're the judge and only a fool criticizes or questions the judge, even after a trial, if it's believed that some day they may be judged again.
Gary
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
